SLE Stock Tickeron detected bearish Stock Pattern: Broadening Wedge Ascending on September 29, 2026
at Tickeron.com
A.I.dvisor detected a bearish Broadening Wedge Ascending pattern for SLE stock. This pattern was detected on September 29, 2026 . The odds of reaching the target price are 8.
The Broadening Wedge Ascending pattern forms when a security price progressively makes higher highs (1, 3, 5) and higher lows (2, 4), following two widening trend lines.
Consider selling the security short or buying a put option at the downward breakout price level, which is the last low that touches the bottom line (4).
SLE's Stochastic Oscillator reaches into overbought zone
The Stochastic Oscillator for SLE moved into overbought territory on October 01, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
SLE broke above its upper Bollinger Band on September 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 29, 2026. You may want to consider a long position or call options on SLE as a result. In 66 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.
The Moving Average Convergence Divergence (MACD) for SLE just turned positive on September 29, 2026. Looking at past instances where SLE's MACD turned positive, the stock continued to rise in 39 of 41 cases over the following month. The odds of a continued upward trend are 90%.
Following a +5.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where SLE advanced for three days, in 174 of 219 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.698) is normal, around the industry mean (1.315). P/E Ratio (0.039) is within average values for comparable stocks, (405.942). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (17.274). Dividend Yield (0.000) settles around the average of (0.015) among similar stocks. P/S Ratio (0.654) is also within normal values, averaging (70.877).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. SLE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.